Daphne Jane Holt, M.D., Ph.D.
This page shows the publications co-authored by Daphne Holt and Oliver Freudenreich.
Stimulant misuse in college for "pseudo-attention deficit disorder" during schizophrenia prodrome. Am J Psychiatry. 2006 Nov; 163(11):2019.
Neural Abnormalities in Fear Generalization in Schizophrenia and Associations With Negative Symptoms. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jan 29.
Dysfunction of a cortical midline network during emotional appraisals in schizophrenia. Schizophr Bull. 2011 Jan; 37(1):164-76.
The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis. Harv Rev Psychiatry. 2007 Sep-Oct; 15(5):189-211.
Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia. J Clin Psychopharmacol. 2021 May-Jun 01; 41(3):244-249.
Effect of citalopram on hippocampal volume in first-episode schizophrenia: Structural MRI results from the DECIFER trial. Psychiatry Res Neuroimaging. 2021 06 30; 312:111286.
Air pollution and hippocampal atrophy in first episode schizophrenia. Schizophr Res. 2020 04; 218:63-69.
Citalopram in first episode schizophrenia: The DECIFER trial. Schizophr Res. 2019 06; 208:331-337.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.